Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-064301
Filing Date
2025-06-30
Accepted
2025-06-30 20:35:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 13405
  Complete submission text file 0001104659-25-064301.txt   15156
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Subject) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90544 | Film No.: 251093870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2120 COLORADO AVENUE, #230 SANTA MONICA CA 90404
Business Address 2120 COLORADO AVENUE, #230 SANTA MONICA CA 90404 310-444-4321
Acuitas Group Holdings, LLC (Filed by) CIK: 0001797168 (see all company filings)

EIN.: 270901060 | State of Incorp.: CA
Type: SCHEDULE 13D/A